FRE — Firebrick Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- AU$8.56m
- AU$7.23m
- AU$0.11m
Annual cashflow statement for Firebrick Pharma, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -2.81 | -4.25 | -2.46 | -1.13 | -1.21 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.2 | -5.78 | -2.34 | -1.78 | -2.6 |
| Capital Expenditures | -0.033 | -0.002 | -0 | -0.083 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.033 | -0.002 | -0 | -0.083 | 0 |
| Financing Cash Flow Items | -0.474 | -0.006 | -0.005 | 0.095 | -0.127 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.2 | 0.997 | 0.815 | 2.02 | 2.94 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.99 | -4.79 | -1.53 | 0.159 | 0.338 |